RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Acronyms RETRO CRVO
- Sponsors Bayer
- 29 Jan 2018 Status changed from active, no longer recruiting to completed.
- 21 Nov 2017 Planned End Date changed from 31 Aug 2017 to 30 Nov 2017.
- 21 Nov 2017 Planned primary completion date changed from 31 Aug 2017 to 30 Nov 2017.